Surgical planning tool
This article was originally published in The Gray Sheet
Executive Summary
Belgium firm Materialise announces Sept. 17 plans for a randomized trial comparing standard X-ray-based surgical planning for wrist surgery and computer-assisted/computed tomography-based planning using the firm's 510(k)-cleared SurgiCase system. Materialise's technology or similar technology is marketed by several of the top orthopedics device firms as an add-on to their knee implant offerings (1"The Gray Sheet" Aug. 30, 2010)
You may also be interested in...
FDA Warning Letters Target Personalized Knee Surgery Systems
FDA's device center is warning two different orthopedic firms that the companies' personalized knee surgery instrumentation systems are being marketed without proper clearance or approval
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.